Polpharma European CDMO Partner & API Manufacturer since 1951

Polpharma European CDMO Partner & API Manufacturer since 1951

X

CAS 52187-19-6 manufacturers and suppliers on PharmaCompass

Product

CAS 52187-19-6

CAS 52187-19-6

Chemistry, 6 End Use API, 3 Related Intermediates

Manufacturers/Suppliers

6 Suppliers

6 Suppliers

CAS 52187-19-6

Also known as: Zinc5762611, (3as)-3aalpha,4,9,9aalpha-tetrahydro-2,2-dimethylnaphtho[2,3-d]-1,3-dioxol-5-ol

Molecular Formula

C₁₃H₁₆O₃

Molecular Weight

220.26 g/mol

InChI Key

VHQZRMCDYDICCK-NEPJUHHUSA-N

1 2D Structure

CAS 52187-19-6

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

(3aS,9aR)-2,2-dimethyl-3a,4,9,9a-tetrahydrobenzo[f][1,3]benzodioxol-5-ol

2.1.2 InChI

InChI=1S/C13H16O3/c1-13(2)15-11-6-8-4-3-5-10(14)9(8)7-12(11)16-13/h3-5,11-12,14H,6-7H2,1-2H3/t11-,12+/m1/s1

2.1.3 InChI Key

VHQZRMCDYDICCK-NEPJUHHUSA-N

2.1.4 Canonical SMILES

CC1(OC2CC3=C(CC2O1)C(=CC=C3)O)C

2.1.5 Isomeric SMILES

CC1(O[C@@H]2CC3=C(C[C@@H]2O1)C(=CC=C3)O)C

2.2 Synonyms

2.2.1 Depositor-Supplied Synonyms

1. Zinc5762611

2. (3as)-3aalpha,4,9,9aalpha-tetrahydro-2,2-dimethylnaphtho[2,3-d]-1,3-dioxol-5-ol

2.3 Create Date

2007-02-07

3 Chemical and Physical Properties

Molecular Formula	C₁₃H₁₆O₃
Molecular Weight	220.26 g/mol
XLogP3	2.2
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	3
Rotatable Bond Count	0
Exact Mass	220.109944368 g/mol
Monoisotopic Mass	220.109944368 g/mol
Topological Polar Surface Area	38.7 Å²
Heavy Atom Count	16
Formal Charge	0
Complexity	276
Isotope Atom Count	0
Defined Atom Stereocenter Count	2
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

List of Suppliers

Full View Screen

Full Screen View

price-trend

Huvepharma Italia S.r.l

Contact Supplier

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

Post an Enquiry

Italy

Digital Content

Methylphenylcyclohexyl glycolate

PDF Supplier PDF

URL Supplier Web Content

CAS Number

10399-13-0

End Use API

Oxybutynin Hydrochloride

About the Company

Huvepharma® Italia is a fast-growing global pharmaceutical company duly organized for developing, manufa...

Huvepharma® Italia is a fast-growing global pharmaceutical company duly organized for developing, manufacturing and marketing advanced intermediates and active pharmaceutical ingredients by chemical synthesis for both human and animal health. The focus is specifically on offering services for developing and industrializing new molecules for start-up companies, always operating in a certified GMP environment. Huvepharma® Italia is also particularly active with proven expertise in the fight against malaria disease. Huvepharma® Italia is a privately-owned company, headquartered in Garessio (CN) – Italy, employing about 150 people.

ASK
US

Upload
your Marketing & Sales content

minakem-m-2024-05-27

Access Virtual Booth

Contact Supplier

Bora Pharmaceuticals- Making success more certain.

Access Virtual Booth

Contact Supplier

Market Place

Home

Menu

Post Enquiry

Market Place

Search